© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity

Top section

Top section

I thought the grass would be greener in fintech land, but it’s patchy and dreary
Hybrid capital is open to the big US tech companies. But who needs an umbrella when the sun is shining?
Years of underperformance are behind it and the bank has launched a new growth plan
More articles

More articles

More articles

  • New sustainable DCM team at Citi — Deutsche picks Stergiou for new position — SMBC Nikko makes ABS trading hire
  • Commerzbank’s future strategy is up in the air after it was announced that its chief executive and chairman would be leaving after its “5.0” strategy received a poor welcome.
  • Equity investors are turning their focus away from rescue capital raises and towards other long-term priorities after the initial shock of the Covid-19 outbreak. At the beginning of the year, increased investor scrutiny of environmental, social and governance (ESG) factors was on the tip of all tongues in Europe’s equity capital markets, and it is now featuring heavily in conversations again.
  • UK chancellor of the exchequer Rishi Sunak announced a stimulus package totalling up to £30bn on Wednesday, driving a wedge between some bankers and investors about how big an impact the measures will have on the capital markets.
  • Bohai Bank wrapped up a billion-dollar-plus Hong Kong IPO this week. The issuer, one of China’s last remaining joint-stock commercial banks to go public, rode the tail end of a hot period for the city’s IPO market. Jonathan Breen reports.
  • Hansa Biopharma, the Swedish pharmaceuticals company, raised Skr1.1bn ($121m) through a sale of new shares on Wednesday evening to fund the launch of a new drug for patients undergoing kidney transplants.
shared comment list